Clinic IQ

Our purpose at Clinic IQ is to enhance and improve patient outcomes through the registration of pharmaceutical products. Clinic IQ seeks to fulfil an industry need in the small biotech and pharmaceutical space, by providing innovation and high-level understanding of medical research and clinical trial processes, particularly in clinical trial design. We are working with specialist clinicians to provide their patients access to more effective drugs by either reformulating or repurposing existing TGA-registered drugs. These drugs are already proven to be safe and effective for their current clinical indications and are listed on the TGA's ARTG. Clinic IQ has now established pathways to product development. Each pathway utilises our skills and experience with the aim to bring our drugs to patients as quickly as possible. Our Scientific Advisory Board (SAB) acts as the scientific, research and drug review entity for our Company. The SAB ensures all relevant criteria for any drug is assessed through an initial and ongoing review process, which assists the registration and commercialisation of our products. Through our recently created subsidiary company, CIQ Pharmaceuticals Pty Ltd, we have a pipeline of drugs we aim to register with the TGA, making them available to the Australian market. Together with leading specialists and medical professionals, we seek to engage and partner with healthcare providers, both public and private, to bring our products to patients that otherwise would not be available.